Filing Flows › Comparisons › RGNX vs SCLX
Regenxbio vs Scilex Holding: RGNX and SCLX compared
Regenxbio is the larger company: $9.2M of revenue in its latest quarter (Q3 2026) against $7.6M for Scilex Holding (Q2 2026). Scilex Holding is growing faster (-23% against -69% a year earlier). Scilex Holding is more profitable, with an operating margin of -385.0% against -387.8%.
Where the money goes: RGNX and SCLX
Regenxbio (RGNX) · Q3 2026
Regenxbio, Q3 2026: revenue $9.2M (-69% year over year), operating margin -387.8%, net loss $40.7M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.
Scilex Holding (SCLX) · Q2 2026
Scilex Holding, Q2 2026: revenue $7.6M (-23% year over year), operating margin -385.0%, net loss $115M, operating cash flow −$6.7M. The chart follows the revenue to costs, profit and cash.
| Regenxbio (RGNX) | Scilex Holding (SCLX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $9.2M | $7.6M |
| Revenue growth, Y/Y | -69% | -23% |
| Operating margin | -387.8% | -385.0% |
| Net earnings | −$40.7M | −$115M |
| Net margin | -444.6% | — |
| Operating cash flow | $38.6M | −$6.7M |
| Free cash flow | $38.4M | — |
Where the revenue comes from
Regenxbio
- License and Service: $5.2M (57%)
- Service: $3.9M (43%)
Questions
Which is bigger, Regenxbio or Scilex Holding?
Regenxbio is the larger company: $9.2M of revenue in its latest quarter (Q3 2026) against $7.6M for Scilex Holding (Q2 2026).
Is Regenxbio or Scilex Holding growing faster?
Scilex Holding is growing faster (-23% against -69% a year earlier).
Which is more profitable, Regenxbio or Scilex Holding?
Scilex Holding is more profitable, with an operating margin of -385.0% against -387.8%.
More: Regenxbio earnings · how Regenxbio makes money · Scilex Holding earnings · how Scilex Holding makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.